Summary
In an effort to optimize immunocytochemical methods to evaluate cell kinetics in brain tumors, we studied two newly-developed antibodies which react with formalin resistant epitopes of Proliferating Cellular Nuclear Antigen (PCNA) and Ki-67. These results were compared with standard flow cytometric cell cycle data from the same tumor specimens to determine if these methods correlate with each other, and whether retrospective analysis using these antibodies is feasible for cell kinetic analysis of brain tumors.
Thirty-one specimens of glial tumors submitted for flow cytometry during 1992 were also reacted with antibodies to PCNA (PC-10) and Ki-67 (MIB-1). Flow cytometry scores for S-phase Fraction were compared with immunocytochemical scores for both antibodies, using an arbitrary rating of 1 (low, < 4%), 2 (intermediate, 4–6%), 3 (high, > 6%), and 1 (< 25% positive), 2 (26–75% positive), 3 (> 75% positive), respectively. MIB-1 results were found to correlate significantly with the S-phase fraction as determined by flow cytometry. The MIB-1 data showed a trend toward underestimating, i.e., lower scores, the proliferative index compared with flow cytometry. There was less of a correlation between PC-10 antibody scores and flow cytometry S-phase fraction, as PC-10 immunostaining typically overestimated the proliferative rate of brain tumors when compared with flow cytometry. There was an exact correlation between PC-10 and MIB-1 in only 4 cases, whereas in the remaining specimens, PC-10 results were always higher than MIB-1.
These new immunostaining methods, which react with formalin fixed deparaffinized tissue and require microwave pre-treatment to optimize the results, have demonstrated their usefulness in retrospectively analyzing tumor cell kinetics. For one antibody, namely MIB-1, excellent correlation with standard flow cytometric analysis was achieved. Further studies comparing patient outcome with immunoreactivity to both Ki-67 and PCNA proteins is now possible and may be done on large numbers of achived specimens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Daumas-Duport C: Histological grading of gliomas. Curr Opin Neurol Neurosurg 5(6): 924–931, 1992
Hoshino T: Cell kinetics of glial tumors. Rev Neurol (Paris) 148(6-7): 396–401, 1992
Hoshino T, Ahn D, Prados MD, Lamborn K, Wilson CB: Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Canc 53(4): 550–555, 1993
Allegranza A, Girlando S, Arrigoni GL, Veronese S, Mauri FA, Gambacorta Met al.: Proliferative cell nulear antigen expression in central nervous system neoplasms. Virchows Arch A Pathol Anat Histopathol 419(5): 417–423, 1991
Benjamin DR: Proliferative cell nuclear antigen (PCNA) and pediatric tumors: assessment of proliferative activity. Pediatr Pathol 11(4): 507–519, 1991
Brooks DJ, Garewal HS: Measures of tumor proliferative activity. Int J Clin Lab Res 22(4): 196–200, 1992
Brown DC, Gatter KC: Monoclonal antibody Ki-67: its use in histopathology. Histopathol 17(6): 489–503, 1990
Gerdes J, Lemke H, Baisch H, Wacker H-H, Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-647. J Immunol 133: 1710–1715, 1984
Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134(4): 733–739, 1989
Waseem NH, Lane DP: Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci May; 96 (Pt1): 121–129, 1990
Cattoretti G, Becker MH, Key C, Duchrow M, Schluter C, Galle G, Gerdes J: Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168(4): 357–363, 1992
Shi SR, Key ME, Kalra KL: Antigen retrieval in formalinfixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39(6): 741–748, 1991
Rabinovitch PSet al.: Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 60: 65–71, 1988
Headley DWet al.: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 31: 1333–1335, 1983
Bravo R, Macdonald-Bravo H: Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle associated with DNA replication sites. J Cell Biol 105: 1549–1554, 1987
Galand P, Degraef C: Cyclin/PCNA immunostaining as an alternative to tritiated thymidine pulse labeling for marking S-phase cells in paraffin sections from animal and human tissues. Cell Tissue Kinet 22: 383–392, 1989
Gown AM, de Wever N, Battifora H: Microwave-based antigenie unmasking: A revolutionary new technique for routine immunohistochemistry. Appl Immunohistochem 1: 256–266, 1993
Coltrera MD, Skelly M, Gown AM: Anti-PCNA antibody PC-10 yields unreliable proliferation indexes in routinely processed, deparaffinized formalin-fixed tissue. Applied Immunohistochem 1: 193–200, 1993
Kim DK, Hoyt J, Keles GE, Mass M, Bacchi Cet al.: Detection of pro-liferating cell nuclear antigen (PCNA) in gliomas and adjacent resection margins. Neurosurg 33(4): 619–626, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoyt, J.W., Gown, A.M., Kim, D.K. et al. Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues. J Neuro-Oncol 24, 163–169 (1995). https://doi.org/10.1007/BF01078486
Issue Date:
DOI: https://doi.org/10.1007/BF01078486